XPH icon

SPDR S&P Pharmaceuticals ETF
XPH

Overview Fund Activity

71 hedge funds and large institutions have $105M invested in SPDR S&P Pharmaceuticals ETF in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 10 closing their positions.

Holders
71
Holders Change
-2
Holders Change %
-2.74%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
19
Reduced
22
Closed
10
Calls
$839K
Puts
$1.51M
Net Calls
-$669K
Net Calls Change
-$246K

Top Buyers

1
EH
1
Equitable Holdings
New York
$10.4M
2
Jane Street
2
Jane Street
New York
$2.31M
3
RW
3
Rockport Wealth
Ohio
$1.81M
4
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$1.51M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$286K

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$1.59M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$5.08M
4
LPL Financial
4
LPL Financial
California
$4.52M
5
Bank of America
5
Bank of America
North Carolina
$12.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
FLPIM
76
F.L. Putnam Investment Management
Massachusetts
– -$234K -5,436 Closed
VIM
77
Vista Investment Management
Pennsylvania
– -$221K -5,115 Closed
FIM
78
Fernwood Investment Management
Massachusetts
– -$15.5K -360 Closed
FMII
79
Farmers & Merchants Investments Inc
Nebraska
– -$9.4K -218 Closed
MCM
80
Manchester Capital Management
Vermont
– -$8.63K -200 Closed
RIA
81
Realta Investment Advisors
Delaware
– -$5.31K -123 Closed
Barclays
82
Barclays
United Kingdom
– -$4K -100 Closed
1 2 3
4